跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LENALIDOMIDA SUN 7,5 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
LENALIDOMIDA SUN 7,5 MG CAPSULAS DURAS EFG
Approved
STANDARD
LENALIDOMIDA SUN 7,5 MG CAPSULAS DURAS EFG
Sun Pharmaceutical Industries (Europe) B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Nov 11, 2021
Approval ID
bc4b972ed07b8f5c
Company
Sun Pharmaceutical Industries (Europe) B.V.
Type
Standard
Approval Details
Approval Id
bc4b972ed07b8f5c
Drug Cima Aemps Name
LENALIDOMIDA SUN 7,5 MG CAPSULAS DURAS EFG
Register Number
86255
Holder Company Name
Sun Pharmaceutical Industries (Europe) B.V.
Marketing Company Name
Sun Pharma Laboratorios S.L.
Holder Company Detail Path
/organization/sun-pharmaceutical-industries-europe-b-v
Authorization Date
2021-11-11
Dosage Form
CÁPSULA DURA
Dose
7,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Sun Pharmaceutical Industries (Europe) B.V.
Company Detail Path
/organization/sun-pharmaceutical-industries-europe-b-v
Company Information
Pharmaceutical Company Name
Sun Pharmaceutical Industries (Europe) B.V.
Country Name
Netherlands
City Name
hoofddorp,noord-holland,country_nl
Address
Polarisavenue 87
Active Ingredients
LENALIDOMIDA
7,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Nov 11, 2021
Approval ID
bc4b972ed07b8f5c
Type
Standard
Back to CIMA-AEMPS Approvals